FIELD: chemistry.
SUBSTANCE: group of inventions refers to biotechnology. What is presented is a precursor protein for the recombinant preparation of peptides having a length of a sequence of 5 to 70 amino acid residues. The above protein contains a splittable recurrent sequence of target peptide elements (Pep) and auxiliary peptide elements (Aux) of general formula: (Pep-Aux)x or (Aux-Pep)x, wherein x>1. The elements Aux contain a self-assembled peptide element (SA). The elements Pep contain an amino acid sequence having a length of the sequence of 5 to 70 amino acid residues; ends of the elements comprise splittable sequences, which enable releasing the elements Pep from the precursor protein by specific splitting. There are also presented a nucleic acid molecule with a nucleic acid sequence coding the above precursor protein, an expression cartridge and a recombinant expression vector containing the sequence of the above nucleic acid. There are also presented a variant of the precursor protein, a method for producing the target peptide Pep, as well as using an amphiphilic peptide for the recombinant production of the antimicrobial target peptide.
EFFECT: group of inventions provides the higher yield of the target peptides.
24 cl, 11 dwg, 1 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
CHIMERIC PROTEIN PROVIDING FORMATION OF BIOACTIVE CONFORMATION, METHOD FOR PREPARING PROTEIN WITH INSULIN ACTIVITY, METHOD FOR IDENTIFICATION OF PEPTIDYL FRAGMENT | 1998 |
|
RU2238951C2 |
RECOVERED PEPTIDE EXHIBITING SPECIFIC ANTI-GDF-8 ANTIBODY BINDING ACTIVITY, RECOVERED NUCLEIC ACID MOLECULE, EXPRESSION VECTOR, HOST CELL, METHOD FOR PRODUCING PEPTIDE, VACCINE COMPOSITION AND METHOD OF ELICITING ANTI-GDF-8 IMMUNE RESPONSE, METHOD OF ANTI-GDF-8 ANTIBODY SELECTION SCREENING AND METHOD OF GDF-8 ACTIVITY DOWN-REGULATION IN ANIMAL | 2004 |
|
RU2422460C2 |
NEW GENES CODING NEW PROTEOLYTIC ENZYMES | 2002 |
|
RU2423525C2 |
NEW GENES ENCODING NEW PROTEOLYTIC ENZYMES | 2002 |
|
RU2296160C2 |
GENES AND PROTEINS FOR BIOSYNTHESIS OF LANTIBIOTIC 107891 | 2007 |
|
RU2441915C9 |
METHOD FOR REDUCING DEGREE OF PROTEIN GLYCOSYLATION, METHODS AND PROTEINS | 2010 |
|
RU2575607C2 |
AAV MUTANT WITH ABILITY TO TARGET BRAIN | 2020 |
|
RU2809389C2 |
NEW METHODS FOR DISPLAYING CYCLIC PEPTIDES ON BACTERIOPHAGE PARTICLES | 2015 |
|
RU2702087C2 |
BIOLOGICALLY ACTIVATED DRUGS BASED ON CYTOKINES AND METHODS OF USING THEM | 2019 |
|
RU2819307C2 |
GENE SET EXPRESSION INCLUDING sORF CONSTRUCTS AND METHODS FOR IMMUNOGLOBULIN EXPRESSION | 2006 |
|
RU2478709C2 |
Authors
Dates
2015-04-20—Published
2010-06-02—Filed